Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 15 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 22, 2024 Filed Nov 23, 2024 00:48 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 3,500 | $7.38 | $25,830.00 |
DisclosureSEC source: 0000950170-24-130378 · ownership.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:42 UTC |
Gover Justin D.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069466 · ownership.xml · derivative · entry 1 Gover Justin D. · CIK 0001754129 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:42 UTC |
GANNON STEVENDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069464 · ownership.xml · derivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:43 UTC |
PATOU GARYDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069468 · ownership.xml · derivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:42 UTC |
Machado PatrickDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069467 · ownership.xml · derivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:41 UTC |
Svoronos DawnDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069462 · ownership.xml · derivative · entry 1 Svoronos Dawn · CIK 0001574579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:42 UTC |
GAROFALO ELIZABETH A.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069465 · ownership.xml · derivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 21:41 UTC |
Cannon GillianDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,542 | $0.00 Strike: $38.16 | $0.00 |
DisclosureSEC source: 0000950170-24-069463 · ownership.xml · derivative · entry 1 Cannon Gillian · CIK 0001833910 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,542 Underlying: Common Shares · 15,542 shares Expires 2034-06-04 F1 · derivative.exercise_date: Vesting 100% on the earlier of (i) June 4, 2025 or (ii) the day before the date of the issuer's 2025 annual meeting of shareholders. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:38 UTC |
KENNEY CHRISTOPHER JOHNChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030239 · ownership.xml · derivative · entry 1 KENNEY CHRISTOPHER JOHN · CIK 0001880129 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 18:41 UTC |
AULIN SHERRYChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030245 · ownership.xml · derivative · entry 1 AULIN SHERRY · CIK 0001862144 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 18:34 UTC |
DiFabio AndreaChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030228 · ownership.xml · derivative · entry 1 DiFabio Andrea · CIK 0001692506 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:42 UTC |
Von Seggern ChristopherChief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030250 · ownership.xml · derivative · entry 1 Von Seggern Christopher · CIK 0001821192 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Shares · 100,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:37 UTC |
EMPFIELD JAMES R.EVP, Drug Discovery
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030236 · ownership.xml · derivative · entry 1 EMPFIELD JAMES R. · CIK 0001665430 · EVP, Drug Discovery 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Shares · 65,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:35 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030233 · ownership.xml · derivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Shares · 65,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 11, 2024 Filed Mar 12, 2024 22:33 UTC |
MORTIMER IANDirector · PRESIDENT & CEO
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0000950170-24-030226 · ownership.xml · derivative · entry 1 MORTIMER IAN · CIK 0001619961 · Director · PRESIDENT & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Shares · 250,000 shares Expires 2034-03-10 F1 · derivative.exercise_date: Vesting 25% on January 1, 2025, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:09 UTC |
GAROFALO ELIZABETH A.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,500 | $0.00 Strike: $18.56 | $0.00 |
DisclosureSEC source: 0000950170-24-029542 · ownership.xml · derivative · entry 4 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 20,000 shares Expires 2031-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-third of the total shares subject to the Option vested on the one year anniversary of the grant date, one-third of the total shares subject to the Option vested on the two year anniversary of the grant date, and one-third of the total shares subject to the Option shall vest on the three year anniversary of the grant date. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:09 UTC |
GAROFALO ELIZABETH A.Director
|
SaleCommon Shares | 2,092 | $45.69 | $95,583.48 |
DisclosureSEC source: 0000950170-24-029542 · ownership.xml · nonDerivative · entry 3 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:09 UTC |
GAROFALO ELIZABETH A.Director
|
Tax withholdingCommon Shares | 1,408 | $46.16 | $64,993.28 |
DisclosureSEC source: 0000950170-24-029542 · ownership.xml · nonDerivative · entry 2 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,092 F1 · price: Represents the closing price of the Company's common shares on March 7, 2024 for purposes of net settlement calculations. Read SEC document |
| March 08, 2024 Filed Mar 12, 2024 00:09 UTC |
GAROFALO ELIZABETH A.Director
|
Exercise / conversionCommon Shares | 3,500 | $18.56 | $64,960.00 |
DisclosureSEC source: 0000950170-24-029542 · ownership.xml · nonDerivative · entry 1 GAROFALO ELIZABETH A. · CIK 0001826361 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:28 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 2,000 | $46.20 | $92,402.40 |
DisclosureSEC source: 0000950170-24-028788 · ownership.xml · nonDerivative · entry 4 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000 F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.20 to $46.21, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:28 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 5,000 | $46.30 | $231,512.50 |
DisclosureSEC source: 0000950170-24-028788 · ownership.xml · nonDerivative · entry 3 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 F1 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.3025 to $46.3675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:28 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 5,000 | $46.25 | $231,250.00 |
DisclosureSEC source: 0000950170-24-028788 · ownership.xml · nonDerivative · entry 2 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:28 UTC |
GANNON STEVENDirector
|
SaleCommon Shares | 1,000 | $46.45 | $46,450.00 |
DisclosureSEC source: 0000950170-24-028788 · ownership.xml · nonDerivative · entry 1 GANNON STEVEN · CIK 0001643085 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,407 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · derivative · entry 8 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 7,407 shares Expires 2024-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F5 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,234 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · derivative · entry 7 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 1,234 shares Expires 2024-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. F5 · derivative.exercise_date: The shares subject to this option are fully vested and exercisable. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 6,118 | $46.30 | $283,263.40 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 6 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,398 F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.25 to $46.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
SaleCommon Shares | 1,019 | $46.15 | $47,026.85 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 5 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,516 F3 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $46.15 to $46.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 1,289 | $45.96 | $59,242.44 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 4 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,535 F2 · price: Represents the closing price of the Company's common shares on March 6, 2024 for purposes of net settlement calculations. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 7,407 | $9.85 | $72,958.95 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 3 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Tax withholdingCommon Shares | 215 | $45.96 | $9,881.40 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 2 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,417 F2 · price: Represents the closing price of the Company's common shares on March 6, 2024 for purposes of net settlement calculations. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:31 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
Exercise / conversionCommon Shares | 1,234 | $9.85 | $12,154.90 |
DisclosureSEC source: 0000950170-24-028795 · ownership.xml · nonDerivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The exercise price was converted from $10.78 CAD using the closing rate of exchange of the Bank of Canada on the date of grant, after giving effect to the 1-for-4.86 reverse stock split of the Issuer's outstanding shares effected October 1, 2014 (the "Reverse Stock Split"). The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 21:41 UTC |
ROBIN SHERRINGTONEVP, Strategy & Innovation
|
OtherCommon Shares | 8,398 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000304 · ownership.xml · nonDerivative · entry 1 ROBIN SHERRINGTON · CIK 0001619962 · EVP, Strategy & Innovation 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,398 F1 · kind: Shares were transferred to the Reporting Person's former spouse pursuant to the terms of a settlement agreement dated December 29, 2023 entered into in connection with the dissolution of the Reporting Person's marriage. The Reporting Person no longer reports as beneficially owned any securities owned by his former spouse. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 17:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,497 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-23-071929 · ownership.xml · derivative · entry 4 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,497 shares Expires 2024-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 17:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 823 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-23-071929 · ownership.xml · derivative · entry 3 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 823 shares Expires 2024-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 17:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionCommon Shares | 3,497 | $9.85 | $34,445.45 |
DisclosureSEC source: 0000950170-23-071929 · ownership.xml · nonDerivative · entry 2 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The common shares issued as a result of the exercise are subject to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023. F2 · price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 17:04 UTC |
AZAB MOHAMMADDirector
|
Exercise / conversionCommon Shares | 823 | $9.85 | $8,106.55 |
DisclosureSEC source: 0000950170-23-071929 · ownership.xml · nonDerivative · entry 1 AZAB MOHAMMAD · CIK 0001309653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The common shares issued as a result of the exercise are subject to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023. F2 · price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 14, 2023 Filed Dec 16, 2023 02:50 UTC Amendment |
PATOU GARYDirector
|
SaleCommon Shares | 7,598 | $41.05 | $311,897.90 |
DisclosureSEC source: 0000950170-23-070912 · ownership.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 4,902 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F2 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F3 · ownership.nature: By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,144 | $0.00 Strike: $9.00 | $0.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · derivative · entry 13 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 5,144 shares Expires 2024-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,800 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · derivative · entry 12 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,800 shares Expires 2024-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,378 | $0.00 Strike: $9.85 | $0.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · derivative · entry 11 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,378 shares Expires 2024-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 7,598 | $41.05 | $311,897.90 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 10 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note Disclosed balance after: 4,902 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F6 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. F7 · ownership.nature: By Gary & Karen Barbara Patou TTEE Patou Family Trust FBO Gary Patou Karen Barbara Patou. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 3,977 | $39.84 | $158,443.68 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 9 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 1,167 | $39.68 | $46,306.56 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 8 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,550 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F3 · price: Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 5,144 | $9.00 | $46,296.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 7 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 2,303 | $39.10 | $90,047.30 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 6 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F5 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 577 | $39.68 | $22,895.36 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 5 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,876 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F3 · price: Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 2,880 | $9.85 | $28,368.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 4 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F2 · price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
SaleCommon Shares | 5,100 | $38.94 | $198,594.00 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 3 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,573 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F4 · price: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.81 to $39.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Tax withholdingCommon Shares | 1,278 | $39.68 | $50,711.04 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 2 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,673 F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F3 · price: Represents the closing price of the Company's common shares in U.S. dollars on December 12, 2023, which was converted to a Canadian dollar amount for purposes of net settlement calculations. Read SEC document |
| December 13, 2023 Filed Dec 15, 2023 22:38 UTC |
PATOU GARYDirector
|
Exercise / conversionCommon Shares | 6,378 | $9.85 | $62,823.30 |
DisclosureSEC source: 0000950170-23-070841 · ownership.xml · nonDerivative · entry 1 PATOU GARY · CIK 0001283535 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the terms of a Lock-Up Agreement executed by the Reporting Person in favor of the underwriters of the Company's follow-on public offering in November 2023, the Reporting Person is permitted to transfer up to 22,000 common shares beneficially owned prior to November 29, 2023 or received upon the exercise of an option to purchase common shares during the lock-up period. F2 · price: The exercise price was converted to U.S. dollars from $10.78 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.